new crypto coin- Top snippets

Analysis and interpretation of artificial intelligence, semiconductor, medicine and Hong Kong stock technology!Analysis and interpretation of artificial intelligence, semiconductor, medicine and Hong Kong stock technology!

1. The artificial intelligence sector gapped higher above the 20-day moving average in early trading, and the initial increase was close to 4%. However, after the expectation that the multi-period moving average will stick upward was fulfilled, there was a wave of action to accelerate the diving, which made up for the big gap that opened higher in the day, which cleared an obstacle for the next pull-up.3. Catalyzed by the deregulation of innovative drugs by the Biosafety Law of the United States, the pharmaceutical sector has gone out of a continuous rebound trend, especially the Pharmaceutical Department has ushered in some performance opportunities. However, before the revenue is gradually transferred from the US market, it will be easily grasped by others.

2. In the case of a breakthrough in the substitution of domestic chips, our side suddenly attacked NVIDIA last night, causing it to drop by 2.55%, which obviously stimulated the market sentiment, making the semiconductor sector change yesterday's decline, ushered in a retaliatory rebound, and formed a strong "Yang Bao Yin" form. However, while rejoicing, don't underestimate the determination of the United States to counter it.2. In the case of a breakthrough in the substitution of domestic chips, our side suddenly attacked NVIDIA last night, causing it to drop by 2.55%, which obviously stimulated the market sentiment, making the semiconductor sector change yesterday's decline, ushered in a retaliatory rebound, and formed a strong "Yang Bao Yin" form. However, while rejoicing, don't underestimate the determination of the United States to counter it.3. Catalyzed by the deregulation of innovative drugs by the Biosafety Law of the United States, the pharmaceutical sector has gone out of a continuous rebound trend, especially the Pharmaceutical Department has ushered in some performance opportunities. However, before the revenue is gradually transferred from the US market, it will be easily grasped by others.